Strengthening Exercises in Shoulder Impingement (SExSI) Trial

Sponsor
Copenhagen University Hospital, Hvidovre (Other)
Overall Status
Completed
CT.gov ID
NCT02747251
Collaborator
Metropolitan University College (Other), University of Copenhagen (Other), Aalborg University (Other)
200
1
2
37.6
5.3

Study Details

Study Description

Brief Summary

This study evaluates the addition of a high dose of simple home-based elastic band strengthening exercises to usual care in patients with subacromial impingement syndrome. Half of the participants receive instructions in simple home-based elastic band strengthening exercises in addition to usual care, while the other half receive usual care.

Condition or Disease Intervention/Treatment Phase
  • Other: Strengthen your Shoulder
  • Other: Usual Care
N/A

Detailed Description

The SEXSI trial is a pragmatic, assessor and participant blinded, randomized, controlled, superiority trial, with a two-group parallel design. Patients with subacromial impingement syndrome will be randomized to either usual care or a home-based intervention consisting of progressive high volume resistance training in addition to usual care using a 1:1 allocation. The primary end-point will be change in the Shoulder Pain and Disability Index (SPADI) 16 weeks after baseline.

The overall frame for the trial is a main clinical effectiveness-part and an embedded mechanistic part. The clinical effectiveness-part will be reported in the main trial paper, and include the following outcomes: SPADI (primary outcome), Abduction strength, External rotation strength, Abduction ROM, Pain last week, QoL-index, QoL-VAS, Global impression of change and PASS. Missing outcome data will be imputed using multiple imputations based on the following variables: All previous scores in the relevant outcome, Age, Gender and Allocation.

A full trial protocol will be published and made publicly available. A constrained Linear Mixed Model (cLMM) will be applied for all continuous outcomes with Time Frame 16 weeks (including the primary outcome), to compare the change from baseline to 16 weeks in the intervention group (IG) to that in the control group (CG). The outcome at 16 weeks will be included as dependent variable, treatment group (IG or CG) as main effect and both baseline score and any additional follow up measurements as repeated measurements. The covariance structures will be selected based on the MAICE procedure. Binary outcomes will be reported as proportions with corresponding 95% confidence intervals, and will be compared using Chi-squared tests, and Odds Ratios computed from random effects logistic regression models. All of these analyses will be conducted as intention to treat (ITT) analyses, including all randomized participants, regardless of protocol adherence, meaning that all participants will be analysed as randomized. In the primary trial report, all collected outcomes will be listed, and it will be stated that the below-mentioned variables - belonging to the mechanistic part - will be reported in secondary publications.

The mechanistic part will be reported in secondary papers with a clear reference to the primary trial and trial registration, and it will hold the label "secondary analyses from a pragmatic randomized controlled trial" in the title. The following outcomes will be reported:

Outcomes regarding pain sensitization (temporal summation of pain, conditioned pain modulation, pain pressure threshold and pain catastrophizing) will be reported in a subsequent paper where we also plan to investigate:

  • the modifying effects of pain sensitization on the effectiveness of the add-on intervention

  • the dose-response relationship between objectively monitored adherence to the add-on intervention and change in SPADI, shoulder abduction strength and external rotation strength

  • the dose-response relationship between pain sensitization and change in SPADI, shoulder abduction strength and external rotation strength, and to what degree this is mediated through adherence to the intervention.

Outcomes regarding scapula dyskinesia and scapula dysfunction will be reported in another subsequent paper, were we also plan to investigate the modifying effects of scapula dyskinesia and scapula dysfunction on the effectiveness of the intervention on changes in SPADI, abduction strength and external rotation strength.

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effects of Additional Home-based Strengthening Exercises in Shoulder Impingement Rehabilitation (The SEXSI-Trial): A Pragmatic Randomized Controlled Trial.
Actual Study Start Date :
May 13, 2016
Actual Primary Completion Date :
Oct 29, 2018
Actual Study Completion Date :
Jul 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Strengthen your Shoulder & Usual Care

Instructions in a home-based intervention consisting of progressive high volume resistance training with an elastic band. Instructions provided 0, 2, 5, and 10 weeks after baseline. Usual care includes all treatment received by a patient during the time between baseline and follow-up, except that included in "Strengthen your Shoulder".

Other: Strengthen your Shoulder
A simple home-based elastic band strengthening exercise intervention. This program consists of progressive high volume resistance training exercises with an elastic band.

Other: Usual Care
Usual care, consisting of a referral to general rehabilitation in the municipal under the Danish Health Act § 140, most often with the alternative option to choose a private physiotherapeutic clinic, partly at their own expense. Also includes any additional treatment the patient receives between baseline and follow-up, except that included in "Strengthen your Shoulder".

Active Comparator: Usual Care

Includes all treatment received by a patient during the time between baseline and follow-up, except that included in "Strengthen your Shoulder".

Other: Usual Care
Usual care, consisting of a referral to general rehabilitation in the municipal under the Danish Health Act § 140, most often with the alternative option to choose a private physiotherapeutic clinic, partly at their own expense. Also includes any additional treatment the patient receives between baseline and follow-up, except that included in "Strengthen your Shoulder".

Outcome Measures

Primary Outcome Measures

  1. SPADI [16 weeks]

    Shoulder Pain And Disability Index score (continuous) For all continuous outcomes with Time Frame 16 weeks, a constrained Linear Mixed Model (cLMM) is applied to compare the change from baseline to 16 weeks in the intervention group (IG) to that in the control group (CG), with the outcome at 16 weeks as dependent variable, treatment group (IG or CG) as main effect and both baseline score and any additional follow up measurements as repeated measurements. The covariance structures will be selected based on the MAICE procedure. These analyses will be conducted as intention to treat (ITT) analyses, including all randomized participants, regardless of protocol adherence. Participants will be analysed as randomized.

Secondary Outcome Measures

  1. Abduction strength [16 weeks]

    Maximum isometric voluntary contraction in shoulder abduction (continuous)

  2. External rotation strength [16 weeks]

    Maximum isometric voluntary contraction in shoulder external rotation (continuous)

  3. Abduction ROM [16 weeks]

    Active range of motion in shoulder abduction (continuous)

  4. Pain last week [16 weeks]

    The average of least pain and average pain last week (continuous)

  5. QoL-index [16 weeks]

    Health related Quality of Life measured using the Danish EQ-5D-3L index (continuous)

  6. QoL-index [52 weeks]

    Health related Quality of Life measured using the Danish EQ-5D-3L index (continuous)

  7. QoL-VAS [16 weeks]

    Health related Quality of Life measured using the Danish EQ-5D-3L VAS (continuous)

  8. QoL-VAS [52 weeks]

    Health related Quality of Life measured using the Danish EQ-5D-3L VAS (continuous)

  9. PCS [16 weeks]

    Pain Catastrophizing measured using the Pain Catastrophizing Scale (continuous)

  10. Temporal summation of pain (TS) [16 weeks]

    The increase in pain recorded on an electronic VAS scale (range: 0-10 cm), during repeated standardized pressure induced pain stimuli (continuous)

  11. CPM-Threshold [16 weeks]

    Conditioned pain threshold modulation, the percent increase in pressure pain tolerance threshold, when experimental tonic pain is induced (continuous)

  12. CPM-Detection [16 weeks]

    Conditioned pain detection modulation, the percent increase in pressure pain detection threshold , when experimental tonic pain is induced (continuous)

  13. PPT-deltoid [16 weeks]

    Pain pressure threshold at the deltoid muscle: The pressure applied with a manual algometer when the sensation changes from a sensation of pressure to the first sensation of pain (continuous).

  14. PPT-Supraspinatus [16 weeks]

    Pain pressure threshold at the supraspinatus muscle: The pressure applied with a manual algometer when the sensation changes from a sensation of pressure to the first sensation of pain (continuous).

  15. PPT-Infraspinatus [16 weeks]

    Pain pressure threshold at the infraspinatus muscle: The pressure applied with a manual algometer when the sensation changes from a sensation of pressure to the first sensation of pain (continuous).

  16. PPT-worst [16 weeks]

    Pain pressure threshold at the site of worst pain: The pressure applied with a manual algometer when the sensation changes from a sensation of pressure to the first sensation of pain (continuous).

  17. Sick leave [52 weeks]

    The number of days with reported sick leave due to shoulder disorder (continuous)

  18. Global impression of change [16 weeks]

    Much improved or recovered? (Binary) Binary outcomes will be reported as proportions with corresponding 95% confidence intervals, and will be compared using a Chi-squared tests, and Odds Ratios computed from random effects logistic regression models.

  19. PASS [16 weeks]

    Patient Acceptable Symptom State: Is the symptom state acceptable? (Binary)

  20. Surgery [52 weeks]

    Surgery performed for the shoulder disorder? (Binary)

  21. SDT [16 weeks]

    Scapula dyskinesia measured using the Scapula Dyskinesia Test (Binary)

  22. mSAT [16 weeks]

    Scapula dysfunction measured using the modified Scapula Assistance Test (Binary)

  23. SPADI [52 weeks]

    Shoulder Pain And Disability Index score (continuous)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Convened for the first time to the clinic, for examination of their current shoulder disorder

  • Shoulder disorder lasting at least three months

  • Living in Capitol Region of Denmark

  • Not pregnant

  • Do not permanently use strong pain medication

  • Able to understand spoken and written Danish

  • ≥3 positive of the five diagnostic test for subacromial impingement syndrome (Hawkins-Kennedy test, Neer's test, pain-full arc, Resisted External Rotation test and Jobe's test)

  • Offered a rehabilitation plan due to a medically justified need for general rehabilitation after discharge from the hospital under the Danish Health Act § 140.

  • Completed Shoulder Pain And Disability Index (SPADI) questionnaire on the day of the medical examination

Exclusion Criteria:
  • A radiologically verified new or previous fracture related to the shoulder joint, including the scapula

  • Clinically suspected Glenohumeral osteoarthritis

  • A clinically suspected luxation or sub-luxation of the glenohumeral, acromioclavicular or sternoclavicular joint

  • A clinically suspected labral lesion, complete tear of the rotator cuff, frozen shoulder or other competing diagnoses (i.e. rheumatoid arthritis, cancer, neurological disorders, fibromyalgia, psychiatric illness)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Orthopaedic Department, Hvidovre Hospital Hvidovre Denmark 2650

Sponsors and Collaborators

  • Copenhagen University Hospital, Hvidovre
  • Metropolitan University College
  • University of Copenhagen
  • Aalborg University

Investigators

  • Principal Investigator: Mikkel B Clausen, PhD-Student, Bachelor's Degree Programme in Physiotherapy, Department of Physiotherapy and Occupational Therapy, Faculty of Health and Technology, Metropolitan University College

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mikkel Bek Clausen, PhD-Student, Copenhagen University Hospital, Hvidovre
ClinicalTrials.gov Identifier:
NCT02747251
Other Study ID Numbers:
  • H-16016763
First Posted:
Apr 21, 2016
Last Update Posted:
Jan 23, 2020
Last Verified:
Jan 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Mikkel Bek Clausen, PhD-Student, Copenhagen University Hospital, Hvidovre
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 23, 2020